Morgan Stanley’s ENVUE MEDICAL INC NEW FEED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-833
Closed -$23.8K 8531
2026
Q1
$23.8K Buy
+833
New +$21.6K ﹤0.01% 6659
2025
Q4
Sell
-83
Closed -$5.64K 8384
2025
Q3
$5.64K Buy
83
+74
+822% +$6.68K ﹤0.01% 7058
2025
Q2
$954 Sell
9
-104
-92% -$37.2K ﹤0.01% 7339
2025
Q1
$46.4K Buy
+113
New +$62.2K ﹤0.01% 6293
2024
Q2
Hold
0
-$9 7928
2024
Q1
Hold
0
7775
2023
Q4
Hold
0
7751
2023
Q3
Hold
0
7538
2023
Q2
Hold
0
7559
2023
Q1
Hold
0
7624
2022
Q4
Hold
0
7734
2022
Q3
Hold
0
7816
2022
Q2
Hold
0
7910
2022
Q1
Sell
-4
Closed -$90.6K 8060
2021
Q4
$115K Buy
4
+3
+300% +$107K ﹤0.01% 6354
2021
Q3
$40K Buy
+1
New +$53.2K ﹤0.01% 6810
2019
Q4
Hold
0
6717
2019
Q3
Hold
0
6709
2019
Q2
Hold
0
6705
2019
Q1
Hold
0
6664
2018
Q3
Hold
0
6763
2018
Q2
Hold
0
6716

Other funds holding FEED

Morgan Stanley's FEED Position: Q2 2026 in Review

Morgan Stanley sold out of ENVUE MEDICAL INC NEW (FEED) in Q2 2026, closing a stake of 833 shares — an estimated $23.8K sold.

Morgan Stanley first reported a position in FEED in Q3 2021 and held it in 6 quarters. The position peaked at $115K in Q4 2021. 12 funds tracked by Wall St. Rank hold FEED as of Q2 2026.

  • Morgan Stanley reported no remaining ENVUE MEDICAL INC NEW position as of Q2 2026 after selling out during the quarter.
  • Morgan Stanley sold 833 ENVUE MEDICAL INC NEW shares in Q2 2026, an estimated $23.8K.
  • Morgan Stanley first reported a position in ENVUE MEDICAL INC NEW in Q3 2021 and held it in 6 quarters.
  • Morgan Stanley's ENVUE MEDICAL INC NEW position peaked at $115K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held ENVUE MEDICAL INC NEW as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.